EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain

Serafín Sánchez-Gómez, Rubén Polo, Francisco Ibáñez-Ortigosa, Óscar Martínez-Pérez, Víctor Zamora, Jesús Cuervo

Frontiers in Public Health · 24.06.2026 · 14

DOI: 10.3389/fpubh.2026.1829029 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 24.06.2026. Verfasst von Serafín Sánchez-Gómez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Head and Neck Surgery, Hospital Universitario Virgen Macarena, Sevilla, Spain. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Hearing Aids, Bone Conduction, Hearing Loss. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the cost-effectiveness of the transcutaneous bone-conduction hearing implant Osia® System compared to the percutaneous bone-conduction hearing implant Baha® Connect System in a pooled population of adults eligible for bone-conduction hearing implants, from the perspective of the Spanish National Health System.

Methods

A lifetime Markov model with 6-month cycles was simulated based on a previously published Swedish study, incorporating three primary health states: “with implant,” “without implant,” and “dead.” Clinical inputs included probabilities of adverse events (e.g., complications, device failure), health utilities in Quality-Adjusted Life Years (QALYs), and direct healthcare costs. Costs and QALYs were discounted at a 3% annual rate. Deterministic and probabilistic sensitivity analysis were conducted to assess the uncertainty of the model parameters.

Results

In the base-case analysis, the Osia® System incurred a total cost of €24,555 per patient and yielded 15.94144 QALYs, while the Baha® Connect System accounted for €20,968 and generated 15.17033 QALYs. The incremental cost-effectiveness ratio (ICER) of the Osia® System was €4,651/QALY gained, compared to the Baha® Connect System. The model was most sensitive to utility values for each device. At a willingness-to-pay threshold of €30,000/QALY, the probabilistic sensitivity analysis showed that the Osia® System had a 62% probability of being cost-effective.

Conclusion

From the Spanish healthcare system perspective, the Osia® System is a cost-effective alternative to the Baha® Connect System for the overall adult patient population with hearing loss in Spain eligible for a bone-conduction hearing implant. These results support its inclusion in national coverage and reimbursement policies to improve clinical and patient-reported outcomes and to promote sustainable healthcare delivery. However, these findings should be interpreted cautiously due to the reliance on non-Spanish clinical inputs and the absence of subgroup-specific analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisHearing AidsBone ConductionHearing LossSpainHumansCost-Effectiveness AnalysisQuality-Adjusted Life YearsMarkov ChainsFemaleAdultMiddle AgedMaleAged

Stichwörter der Autor:innen

Osia® systemSpainbone conduction hearing implantscost-utility analysishealth economicshearing loss

Autor:innen und Institutionen

  • Department of Otolaryngology and Head and Neck Surgery, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Department of Otolaryngology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Axentiva Solutions S.L., Barcelona, Spain.
  • Axentiva Solutions S.L., Oviedo, Spain.

Zitieren

APA

Sánchez-Gómez, S., Polo, R., Ibáñez-Ortigosa, F., Martínez-Pérez, Ó., Zamora, V., & Cuervo, J. (2026). A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1829029

Vancouver

Sánchez-Gómez S, Polo R, Ibáñez-Ortigosa F, Martínez-Pérez Ó, Zamora V, Cuervo J. A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1829029

BibTeX
@article{SnchezGmez2026,
  author = {Sánchez-Gómez, Serafín and Polo, Rubén and Ibáñez-Ortigosa, Francisco and Martínez-Pérez, Óscar and Zamora, Víctor and Cuervo, Jesús},
  title = {A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1829029}
}
Kostenlos starten →